Faculty Opinions recommendation of Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease.
2017 ◽
2004 ◽
Vol 1
(2)
◽
pp. 111-117
◽